TriLink BioTechnologies

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Research & Development

TriLink BioTechnologies licenses Quantoom Biosciences' mRNA capping technology

Quantoom will incorporate TriLink's CleanCap mRNA capping technology into its (sa)mRNA development platform, Ntensify
Analysis

The analytics advancements driving mRNA breakthroughs

mRNA therapeutics are attracting attention because they can be manufactured rapidly to treat previously undruggable diseases
Ingredients

TriLink offers new GMP-grade material for mRNA manufacturing

N1-Methyl-Pseudouridine-5’-Triphosphate, a critical raw material for mRNA manufacturing, allows researchers to accelerate their drug discovery and development
Design & Build

TriLink to open GMP facility aimed at early phase therapeutic manufacturing

Plant will be fully operational by July
Design & Build

TriLink BioTechnologies to work with American Cleanroom Systems to build cGMP facility

Will contain nine labs and is scheduled to be completed in the first quarter of 2014
Subscribe now